Literature DB >> 197012

Properties of density gradient-fractionated peripheral blood leukocytes from cattle infected with bovine leukemia virus.

S J Kenyon, C E Piper.   

Abstract

Discontinuous bovine serum albumin gradients were used to fractionate peripheral blood leukocytes from bovine leukemia virus (BLV)-free and BLV-infected cows. The release of infectious BLV and spontaneous incorporation of [3H]thymidine were not properties of density gradient-fractionated leukocytes from a BLV-free cow. When leukocytes from BLV-infected cattle were fractionated, B lymphocytes which spontaneously incorporated [3H]thymidine could be separated as a distinct subpopulation from B lymphocytes which replicated infectious BLV. Density gradient fractionation of leukocytes from a cow with lymphosarcoma is also reported. A fall in lymphocyte count at the time of tumor development is attributed to the loss of B lymphocytes which spontaneously incorporate [3H]thymidine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 197012      PMCID: PMC421047          DOI: 10.1128/iai.16.3.898-903.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

Review 1.  Receptors for complement and immunoglobulin on human and animal lymphoid cells.

Authors:  E M Shevach; E S Jaffe; I Green
Journal:  Transplant Rev       Date:  1973

2.  B-cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein-Barr virus.

Authors:  P K Pattengale; R W Smith; P Gerber
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

3.  Thymus and bone marrow derived lymphatic leukaemia in mice.

Authors:  N Haran-Chera; A Peled
Journal:  Nature       Date:  1973-02-09       Impact factor: 49.962

4.  Serological detection of type C viruses found in bovine cultures.

Authors:  J F Ferrer; L Avila; N D Stock
Journal:  Cancer Res       Date:  1972-09       Impact factor: 12.701

5.  Replicating C-type virus in phytohemagglutinin-treated buffy-coat cultures of bovine origin.

Authors:  N D Stock; J F Ferrer
Journal:  J Natl Cancer Inst       Date:  1972-04       Impact factor: 13.506

6.  Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma.

Authors:  J M Miller; L D Miller; C Olson; K G Gillette
Journal:  J Natl Cancer Inst       Date:  1969-12       Impact factor: 13.506

7.  Cellular basis of persistent lymphocytosis in cattle infected with bovine leukemia virus.

Authors:  S J Kenyon; C E Piper
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

8.  Group-specific antigen expression during embryogenesis of the genome of the C-type RNA tumor virus: implications for ontogenesis and oncogenesis.

Authors:  R J Huebner; G J Kelloff; P S Sarma; W T Lane; H C Turner; R V Gilden; S Oroszlan; H Meier; D D Myers; R L Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

9.  Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction.

Authors:  L B Olding; F C Jensen; M B Oldstone
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

10.  The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines.

Authors:  M Nowakowski; J D Feldman; S Kano; B R Bloom
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

  10 in total
  11 in total

1.  The pX region of the bovine leukemia virus is transcribed as a 2.1-kilobase mRNA.

Authors:  R Z Mamoun; T Astier-Gin; R Kettmann; J Deschamps; N Rebeyrotte; B J Guillemain
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

2.  Phytohemagglutinin activation of the transcription of the bovine leukemia virus genome requires de novo protein synthesis.

Authors:  R Chatterjee; P Gupta; S V Kashmiri; J F Ferrer
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

3.  An improved syncytia infectivity assay for the bovine leukemia virus.

Authors:  C A Diglio; C E Piper; J F Ferrer
Journal:  In Vitro       Date:  1978-06

4.  Levamisole does not affect the virological and serological responses of bovine leukemia virus-infected cattle and sheep.

Authors:  M J Van der Maaten; M J Schmerr; J M Miller; J M Sacks
Journal:  Can J Comp Med       Date:  1983-10

5.  Cellular basis of persistent lymphocytosis in cattle infected with bovine leukemia virus.

Authors:  S J Kenyon; C E Piper
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

6.  Factors affecting the infectivity of lymphocytes from cattle with bovine leukosis virus.

Authors:  B A Buxton; R D Schultz
Journal:  Can J Comp Med       Date:  1984-10

7.  Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic.

Authors:  R Kettmann; Y Cleuter; M Mammerickx; M Meunier-Rotival; G Bernardi; A Burny; H Chantrenne
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

8.  Relation of Bovine leukosis virus production on cell growth cycle.

Authors:  I Takashima; C Olson
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

9.  Evidence that the spontaneous blastogenesis of lymphocytes from bovine leukemia virus-infected cattle is viral antigen specific.

Authors:  R M Thorn; P Gupta; S J Kenyon; J F Ferrer
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

10.  Inhibition of protein kinase C results in decreased expression of bovine leukemia virus.

Authors:  W A Jensen; B J Wicks-Beard; G L Cockerell
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.